Ignite Creation Date:
2024-05-05 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 9:54 AM
Study NCT ID:
NCT00741325
Status:
COMPLETED
Last Update Posted:
2014-02-11
First Post:
2008-08-22
Brief Title:
Long-Term Follow-up Study for Non-Hodgkins Lymphoma Patients Who Received Study Treatment Plerixafor or Placebo in the AMD3100-3101 Study NCT00103610
Sponsor:
Organization:
Sanofi
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
178
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: